De Novo Protein Sequencing: Technical Principles and Method Overview

De Novo Protein Sequencing is a technique that deciphers the primary structure (amino acid sequence) of proteins directly without the need for reference genomes or databases. This method is significant for studying unknown proteins, developing antibody drugs, analyzing proteomics of non-model organisms, and investigating post-translational modifications (PTMs). Traditional protein sequencing relies on genome data or known protein databases, but its limitations become apparent when dealing with new species, mutants, or samples with complex PTMs. De Novo Protein Sequencing has emerged as a powerful tool for exploring unknown proteins, deriving amino acid sequences directly from mass spectrometry data without prior sequence information.

 

1. Basic Principles of De Novo Protein Sequencing

Proteins are linear molecules formed by amino acids linked by peptide bonds, and their function and structure depend on the amino acid sequence. The core task of de novo sequencing is to deduce the complete amino acid sequence by analyzing mass spectrometry data of proteins or peptide fragments. Without reference databases, de novo sequencing requires precise mass spectrometry to resolve amino acid residues and their sequence information.

 

Typically, de novo protein sequencing relies on mass spectrometry, particularly Tandem Mass Spectrometry (MS/MS). In MS/MS experiments, the target protein is first digested (usually using trypsin, Lys-C, or Asp-N) or chemically degraded (such as Edman degradation) to obtain shorter peptides. These peptides are ionized in the mass spectrometer and enter the fragmentation chamber, producing fragment ions with specific fragmentation patterns. Based on these fragment ion signals, the sequence information of the peptides can be deduced.

 

2. Common Methods and Procedures of De Novo Protein Sequencing

De novo protein sequencing typically includes several key steps:

1. Sample Preparation and Enzymatic Digestion

After purification, the target protein is usually cleaved using different specificity proteases such as trypsin or pepsin to generate small peptides suitable for analysis.

 

2. Mass Spectrometry Data Acquisition

High-resolution mass spectrometers (such as Orbitrap, TOF, FTICR-MS) are used for primary and secondary mass spectrometry analysis to obtain mass information and fragmentation patterns of the peptides.

 

3. Spectral Analysis and Sequence Deduction

Advanced algorithm software (such as PEAKS, Novor) is used to analyze fragment ion spectra and deduce amino acid sequences based on mass differences between ion pairs.

 

4. Sequence Assembly and Verification

Predicted sequences from different peptides are assembled to form a complete protein sequence, which is then cross-verified with known databases for accuracy.

 

3. Challenges and Future Trends in De Novo Protein Sequencing

1. Technical Challenges

(1) Sequencing Complexity of Complex Samples: The complexity of protein mixtures increases the difficulty of analysis, especially when highly homologous proteins are present.

(2) Interference from Post-Translational Modifications: Certain modifications may affect fragmentation patterns, making peptide sequence analysis more challenging.

(3) Computational Complexity of Data Analysis: High-resolution mass spectrometry data is voluminous and requires efficient algorithms to improve assembly accuracy.

 

2. Future Development Trends

(1) Higher Resolution Mass Spectrometers: Enhance the quality of fragmentation spectra and improve the accuracy of amino acid residue identification.

(2) Artificial Intelligence-Assisted Analysis: Combine deep learning technologies to improve the accuracy and efficiency of de novo sequencing algorithms.

(3) Multi-level Separation Strategies: Combine multidimensional liquid chromatography (LC) and nanospray mass spectrometry (nanospray MS) to enhance the resolution of low-abundance proteins.

 

In non-model organism research, where genomic information is incomplete or lacks databases, de novo protein sequencing can be used to directly identify new proteins and advance biological function studies. Additionally, monoclonal antibodies (mAbs) are important biotherapeutic drugs, and their amino acid sequences directly influence their specificity and stability. De novo sequencing can analyze the sequences of antibody light and heavy chains, providing crucial data for antibody engineering optimization and biosimilar drug development. Furthermore, de novo protein sequencing combined with modification-specific enrichment techniques (such as phosphorylation and glycopeptide enrichment) can resolve modification sites and patterns, aiding in understanding protein functions. With technological advancements, de novo protein sequencing is expected to deeply integrate with genomics and structural biology, propelling life sciences into a new era of 'database-independent' research.Biotechnology CompanyAs a professional provider of high-quality biomass spectrometry multi-omics services, we offer expert de novo protein sequencing services to our clients.

 

Biotechnology Company - Characterization of Bioproducts, High-Quality Multi-Omics Mass Spectrometry Services

 

Related Services: